Global Influenza Vaccine Market 2024-2028

Description

List of Tables

The influenza vaccine market is forecasted to grow by USD 3761.8 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence and incidence of influenza, rising awareness about influenza vaccination, and initiation of immunization programs and research activities.

Technavio's influenza vaccine market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.32%
CAGR	8.09%
Incremental Value	$3761.8 mn

By Distribution Channel

Hospitals and pharmacies
Government and institutional
Others

By Type

Live attenuated influenza vaccines
Recombinant influenza vaccines

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the need for revaccination as one of the prime reasons driving the influenza vaccine market growth during the next few years. Also, surge in number of genetic characterization studies on influenza virus and increase in global travel will lead to sizable demand in the market.

The report on the influenza vaccine market covers the following areas:

Influenza vaccine market sizing
Influenza vaccine market forecast
Influenza vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza vaccine market vendors that include Altimmune Inc., AstraZeneca Plc, Baxter International Inc., BioDiem Ltd., BiondVax Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., FluGen Inc., GlaxoSmithKline Plc, Mitsubishi Chemical Group Corp., Novavax Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Shijiazhuang Yiling Pharmaceutical Co Ltd., SK Chemicals Co. Ltd., Vaccitech Plc, Vaxart Inc., and Vaxine Pty Ltd.. Also, the influenza vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73298

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Influenza Vaccine Market 2018 - 2022
- Historic Market Size - Data Table on Global Influenza Vaccine Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
6.3 Hospitals and pharmacies - Market size and forecast 2023-2028
- Chart on Hospitals and pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals and pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals and pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals and pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Government and institutional - Market size and forecast 2023-2028
- Chart on Government and institutional - Market size and forecast 2023-2028 ($ million)
- Data Table on Government and institutional - Market size and forecast 2023-2028 ($ million)
- Chart on Government and institutional - Year-over-year growth 2023-2028 (%)
- Data Table on Government and institutional - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
7.3 Live attenuated influenza vaccines - Market size and forecast 2023-2028
- Chart on Live attenuated influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Data Table on Live attenuated influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Chart on Live attenuated influenza vaccines - Year-over-year growth 2023-2028 (%)
- Data Table on Live attenuated influenza vaccines - Year-over-year growth 2023-2028 (%)
7.4 Recombinant influenza vaccines - Market size and forecast 2023-2028
- Chart on Recombinant influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Data Table on Recombinant influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Chart on Recombinant influenza vaccines - Year-over-year growth 2023-2028 (%)
- Data Table on Recombinant influenza vaccines - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Altimmune Inc.
- Altimmune Inc. - Overview
- Altimmune Inc. - Product / Service
- Altimmune Inc. - Key news
- Altimmune Inc. - Key offerings
12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
12.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
12.6 BiondVax Pharmaceuticals Ltd.
- BiondVax Pharmaceuticals Ltd. - Overview
- BiondVax Pharmaceuticals Ltd. - Product / Service
- BiondVax Pharmaceuticals Ltd. - Key offerings
12.7 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
12.8 FluGen Inc.
- FluGen Inc. - Overview
- FluGen Inc. - Product / Service
- FluGen Inc. - Key offerings
12.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.10 Mitsubishi Chemical Group Corp.
- Mitsubishi Chemical Group Corp. - Overview
- Mitsubishi Chemical Group Corp. - Business segments
- Mitsubishi Chemical Group Corp. - Key news
- Mitsubishi Chemical Group Corp. - Key offerings
- Mitsubishi Chemical Group Corp. - Segment focus
12.11 Novavax Inc.
- Novavax Inc. - Overview
- Novavax Inc. - Product / Service
- Novavax Inc. - Key offerings
12.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.13 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.14 Shijiazhuang Yiling Pharmaceutical Co Ltd.
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
12.15 SK Chemicals Co. Ltd.
- SK Chemicals Co. Ltd. - Overview
- SK Chemicals Co. Ltd. - Product / Service
- SK Chemicals Co. Ltd. - Key news
- SK Chemicals Co. Ltd. - Key offerings
12.16 Vaccitech Plc
- Vaccitech Plc - Overview
- Vaccitech Plc - Product / Service
- Vaccitech Plc - Key offerings
12.17 Vaxart Inc.
- Vaxart Inc. - Overview
- Vaxart Inc. - Product / Service
- Vaxart Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations